Revenue
2024
2025
AVENUE THERAPEUTICS, INC. (ATXI)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $0 | — | — | — | — | — | — | — | — | — |
| Research & development | $1.0M | $6.6M | $6.1M | $2.7M | $1.3M | $2.9M | $22.2M | $17.7M | $6.7M | $1.3M | $961,000 |
| Operating expenses | $4.5M | $11.3M | — | — | — | — | — | — | — | — | — |
| Operating income | −$3.1M | −$11.3M | −$14.5M | −$8.0M | −$3.7M | −$5.2M | −$26.3M | −$21.8M | −$11.4M | −$2.4M | −$4.8M |
| Net income | −$2.9M | −$11.7M | −$10.5M | −$3.6M | −$3.7M | −$5.2M | −$25.9M | −$21.5M | −$12.3M | −$3.2M | −$5.2M |
| Basic EPSper diluted share | -$0.93 | -$15.79 | -$73.48 | -$1.63 | -$0.22 | -$0.31 | -$1.65 | -$2.10 | -$1.85 | -$1.11 | -$1.93 |
| Diluted EPSper diluted share | — | — | — | — | -$0.22 | -$0.31 | -$1.65 | -$2.10 | -$1.85 | -$1.11 | -$1.93 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 2, 2024Form 4 | Herskowitz NeilDirector | SellCOMMON STOCK, PAR VALUE $0.0001 | 23 | $2.00 | $46.00 | 97 |
| Nov 5, 2024Form 4 | KRANZLER JAY DDirector | SellCOMMON STOCK, PAR VALUE $0.0001 | 61 | $2.24 | $136.64 | 559 |
| Sep 30, 2024Form 4 | KRANZLER JAY DDirector | BuyCOMMON STOCK, PAR VALUE $0.0001 | 497 | $2.50 | $1.2K | 620 |
| Sep 27, 2024Form 4 | KRANZLER JAY DDirector | BuyCOMMON STOCK, PAR VALUE $0.0001 | 3 | $2.40 | $7.20 | 123 |